Santa Barbara-based Celerus Diagnostics said yesterday that it has raised $2.7M in Series A funding from private investors. Celerus is developing a rapid cancer diagnostic product. Investors were not disclosed by the company. Celerus said that it is designing an instrument to decentralize testing and move results closer to patients. More information »